Literature DB >> 3990829

Plasma catecholamines in arterial and capillary blood.

H Baumgartner, C J Wiedermann, H Hörtnagl, V Mühlberger.   

Abstract

Adrenaline and noradrenaline concentrations in arterial and simultaneously collected "arterialised" capillary plasma (vasodilated ear-lobe) obtained from unmedicated resting subjects (n = 9) were measured radio-enzymatically and found to be indistinguishable (adrenaline: 112 +/- 42 ng/l versus 109 +/- 52 ng/l; noradrenaline: 378 +/- 174 ng/l versus 410 +/- 219 ng/l; mean +/- SD; paired t-test: P greater than 0.10). The fitted regression lines did not differ significantly from the line of identity (slope = 1). The correlation coefficient was 0.969 for adrenaline and 0.945 for noradrenaline. Adrenaline and noradrenaline concentrations in plasma from freely flowing capillary blood (non-hyperaemic fingertip) were very similar to those in arterial plasma (adrenaline: 101 +/- 89 ng/l versus 90 +/- 72 ng/l;noradrenaline: 399 +/- 240 ng/l versus 395 +/- 240 ng/l; n = 13 each; paired t-test: P greater than 0.10). The correlation coefficient was 0.981 and 0.917 for adrenaline and noradrenaline, respectively. Adrenaline concentrations in capillary plasma (vasodilated earlobe), however, were significantly higher than those in venous (forearm) plasma (100 +/- 51 ng/l versus 61 +/- 23 ng/l; n = 15; P less than 0.01; capillary-venous difference = 35 +/- 18%) while noradrenaline concentrations did not differ significantly. We conclude that capillary plasma resembles arterial plasma in its catecholamine content and we show that arterial catecholamine levels may be determined in capillary, especially "arterialised" specimens, eliminating the need for arterial blood sampling.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3990829     DOI: 10.1007/bf00692916

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  The acid-base status of the blood.

Authors:  O SIGGAARD-ANDERSEN
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

2.  Adrenaline and potassium: everything in flux.

Authors: 
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

3.  Stress, hypertension, and the heart: the adrenaline trilogy.

Authors: 
Journal:  Lancet       Date:  1982-12-25       Impact factor: 79.321

4.  Adrenergic control of serum potassium.

Authors:  F H Epstein; R M Rosa
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

Review 5.  Relationship between plasma norepinephrine and sympathetic neural activity.

Authors:  D S Goldstein; R McCarty; R J Polinsky; I J Kopin
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

6.  Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stress.

Authors:  J Hilsted; N J Christensen; S Madsbad
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Plasma catecholamines in clinical investigation: a useful index or a meaningless number?

Authors:  E L Bravo; R C Tarazi
Journal:  J Lab Clin Med       Date:  1982-08

Review 8.  Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics.

Authors:  M Esler
Journal:  Clin Sci (Lond)       Date:  1982-03       Impact factor: 6.124

Review 9.  Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions.

Authors:  B Folkow; G F Di Bona; P Hjemdahl; P H Torén; B G Wallin
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

10.  Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.

Authors:  S E Kjeldsen; B Flaaten; I Eide; A Helgeland; P Leren
Journal:  Scand J Clin Lab Invest       Date:  1982-05       Impact factor: 1.713

View more
  7 in total

1.  Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts.

Authors:  Hugh Clements-Jewery; Gajen Sunthar Kanaganayagam; Ruchi Kabra; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Heart rate, metabolic and hormonal responses to maximal psycho-emotional and physical stress in motor car racing drivers.

Authors:  G Schwaberger
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

Review 4.  'Autonomic conflict': a different way to die during cold water immersion?

Authors:  Michael J Shattock; Michael J Tipton
Journal:  J Physiol       Date:  2012-04-30       Impact factor: 5.182

5.  Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 6.  Blood hormones as markers of training stress and overtraining.

Authors:  A Urhausen; H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

7.  Facilitation of ischaemia-induced ventricular fibrillation by catecholamines is mediated by β1 and β2 agonism in the rat heart in vitro.

Authors:  Catherine D E Wilder; Nikoleta Pavlaki; Tutku Dursun; Paul Gyimah; Ellice Caldwell-Dunn; Antonella Ranieri; Hannah R Lewis; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.